D-0198-2025 Class III Ongoing

Recalled by Akron Pharma, Inc. — Fairfield, NJ

FDA drug recall D-0198-2025 was initiated by Akron Pharma, Inc. on Dec 12, 2024 and is designated Class III. Reason for recall: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID. The recall status is ongoing. Affected quantity: 456 bottles.

Recall details

Product Type
Drugs
Report Date
Jan 22, 2025
Initiation Date
Dec 12, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
456 bottles

Product description

Diphenhydramine HCl 25 mg, 1000 Capsules per bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc., 373 RT US 46 W Building E., Suite 117, Fairfield, NJ 07004, NDC 71399-8028-2.

Reason for recall

Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Distribution pattern

Nationwide in the US

Code information

Lot: KDC0124002B Exp 09/30/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0198-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0198-2025. Report a data issue: hello@regdatalab.com.